fda semaglutide compounding news Compounded Semaglutide: Legal & Safe 2025 Compounded GLP-1s: Why doctors worry

The question is, what exactly does this medicine do

no regulatory approval exists as of April 2026 Side effects are primarily gastrointestinal, dose-dependent, and generally manageable with gradual dose escalation It is not commercially available through legitimate channels

The tradeoff is readability

Depending on your response to the medicine, the dose can then be increased to 0.5 mg, then 1 mg, and if clinically required, to 2 mg

Most cases arent misusetheyre accidental dosing errors Confusing units, misreading syringes, or doubling doses can turn a routine shot into a medical emergency

Strumila R et al, Eur Neuropsychopharmacol 2024;87:2934)